Advances in the Management of Hematological Malignancies
This conference will consist of a morning dedicated to the discussion of current advances in the diagnosis and treatment of hematological malignancies including non-hodgkins lymphoma, multiple myeloma, myelodysplastic syndrome and chronic myelogenous leukemia.
Primary Care Physicians, Internists, Medical Oncologists, Radiation Oncologists, Pathologists, Residents, Nursing and Other Health Care Professionals
After attending this conference, the attendees will be able to:
- Describe current and future diagnostic and treatment techniques for hematological malignancies
- Discuss clinical management of patients with hematological cancers
- Review outcomes related to current clinical trials for hematological malignancies
- Identify the new and standard chemotherapy treatment for NHL, MDS, MM and CML
Continuing Medical Education
Danbury Hospital is accredited by the Connecticut State Medical Society to sponsor continuing medical education for physicians.
Danbury Hospital designates this educational activity for a maximum of (3.5) AMA PRA Category 1 Credits™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.
Registered Nurses who attend the entire program will receive 3.5 contact hours. Danbury Hospital is accredited as a provider of Continuing Nursing Education by the Connecticut Nurses' Association an Accredited Approver by the American Nurses Credentialing Center's Commission on Accreditation.
Please call Lillian Monaghan at 203-739-8454 for more information